Fig. 2From: CLN5 in heterozygosis may protect against the development of tumors in a VHL patientqPCR results in HB primary cells, 72 h after transfection with siCLN5 and siScrambled (siScl). Control group was left untreated, while siScl serves as a negative control. The experiment was conducted in triplicates, representing the mean and showing the standard deviation as error bars. aCLN5 expression; bBax expression. Statistical significance is represented as *p < 0.05; **p < 0.01; and ***p < 0.001Back to article page